Simile is a for-profit AI company that sells simulated users — synthetic respondents used in place of, or alongside, human participants in market and product research. It was founded by Joon Sung Park, who holds a PhD from Stanford University (Source: techcrunch.com).
Funding and valuation
| Date | Round | Amount | Valuation | Investors |
|---|---|---|---|---|
| 2026-07-30 | Series B | $200M | $2B | Greenoaks (lead); Index, Hanabi, Bain Capital Ventures, A*, Factory, Definition, CVS Health Ventures |
| 2026-02 (approx.) | Series A | $100M | not disclosed | not disclosed |
The Series B closed on July 30, 2026, roughly five months after a $100 million Series A. CVS, whose venture arm participated in the round, is also a customer (Source: techcrunch.com).
Product
The company sells simulated users for market and product research — model-generated respondents queried in place of, or alongside, recruited human panels (Source: techcrunch.com). How closely the simulated respondents reproduce the populations they stand in for, and how that is validated, is not addressed in the funding coverage.
Relationships
- related: Synthetic Data / Model-Generated Training Data — the underlying technique of substituting generated data for collected data.
- related: Agentic AI — the simulated-user product is a persona-driven application of agent architectures.
- deploys-in: Healthcare — AI Deployment — CVS Health Ventures is both an investor and a customer.